FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775506761> ?p ?o ?g. }

• W2775506761 abstract "Kruppel-like factor 2 (KLF2) is an important zinc-finger transcription factor that maintains endothelial homeostasis by its anti-inflammatory, -thrombotic, -oxidative, and -proliferative effects in endothelial cells. In light of the potent vasoprotective effects of KLF2, modulating KLF2 expression or function could give rise to new therapeutic strategies to treat cardiovascular diseases.High-throughput drug screening based on KLF2 promoter luciferase reporter assay was performed to screen KLF2 activators. Real-time PCR and western blot were used to detect gene and protein expression. Identified KLF2 activator was orally administered to ApoE-/- mice to evaluate anti-atherosclerotic efficacy. By screening 2400 compounds in the Spectrum library, we identified suberanilohydroxamic (SAHA) acid, also known as vorinostat as a pharmacological KLF2 activator through myocyte enhancer factor 2. We found that SAHA exhibited anti-inflammatory effects and attenuated monocyte adhesion to endothelial cells inflamed with tumor necrosis factor alpha. We further showed that the inhibitory effect of SAHA on endothelial inflammation and ensuing monocyte adhesion was KLF2 dependent using KLF2-deficient mouse lung endothelial cells or KLF2 small interfering RNA- depleted human endothelial cells. Importantly, we observed that oral administration of SAHA reduced diet-induced atherosclerotic lesion development in ApoE-/- mice without significant effect on serum lipid levels.These results demonstrate that SAHA has KLF2-dependent anti-inflammatory effects in endothelial cells and provide the proof of concept that KLF2 activation could be a promising therapeutic strategy for treating atherosclerosis." @default.
• W2775506761 created "2017-12-22" @default.
• W2775506761 creator A5014353069 @default.
• W2775506761 creator A5018814025 @default.
• W2775506761 creator A5019842995 @default.
• W2775506761 creator A5022272836 @default.
• W2775506761 creator A5038878574 @default.
• W2775506761 creator A5089382112 @default.
• W2775506761 creator A5091807789 @default.
• W2775506761 date "2017-12-02" @default.
• W2775506761 modified "2023-10-18" @default.
• W2775506761 title "Suberanilohydroxamic Acid as a Pharmacological Kruppel‐Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis" @default.
• W2775506761 cites W1949072443 @default.
• W2775506761 cites W1964220568 @default.
• W2775506761 cites W1982115555 @default.
• W2775506761 cites W1985554823 @default.
• W2775506761 cites W1994267052 @default.
• W2775506761 cites W2002549598 @default.
• W2775506761 cites W2005517764 @default.
• W2775506761 cites W2006793344 @default.
• W2775506761 cites W2015097141 @default.
• W2775506761 cites W2017357456 @default.
• W2775506761 cites W2023388112 @default.
• W2775506761 cites W2026206736 @default.
• W2775506761 cites W2028166507 @default.
• W2775506761 cites W2028952591 @default.
• W2775506761 cites W2036088171 @default.
• W2775506761 cites W2042211035 @default.
• W2775506761 cites W2053542946 @default.
• W2775506761 cites W2066454958 @default.
• W2775506761 cites W2072211942 @default.
• W2775506761 cites W2073054137 @default.
• W2775506761 cites W2073864769 @default.
• W2775506761 cites W2079387460 @default.
• W2775506761 cites W2083215899 @default.
• W2775506761 cites W2096685662 @default.
• W2775506761 cites W2098593685 @default.
• W2775506761 cites W2099300133 @default.
• W2775506761 cites W2100031693 @default.
• W2775506761 cites W2108885374 @default.
• W2775506761 cites W2115147135 @default.
• W2775506761 cites W2116999983 @default.
• W2775506761 cites W2117586093 @default.
• W2775506761 cites W2124860950 @default.
• W2775506761 cites W2126655313 @default.
• W2775506761 cites W2127309246 @default.
• W2775506761 cites W2128876187 @default.
• W2775506761 cites W2133546870 @default.
• W2775506761 cites W2136781803 @default.
• W2775506761 cites W2140915672 @default.
• W2775506761 cites W2144993269 @default.
• W2775506761 cites W2146234609 @default.
• W2775506761 cites W2147919276 @default.
• W2775506761 cites W2169970994 @default.
• W2775506761 cites W2170378264 @default.
• W2775506761 cites W2271364972 @default.
• W2775506761 cites W2356785084 @default.
• W2775506761 cites W2400167361 @default.
• W2775506761 cites W2404556794 @default.
• W2775506761 cites W2415755712 @default.
• W2775506761 cites W2588645651 @default.
• W2775506761 cites W2588973805 @default.
• W2775506761 cites W2592550256 @default.
• W2775506761 cites W2739020588 @default.
• W2775506761 doi "https://doi.org/10.1161/jaha.117.007134" @default.
• W2775506761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5779026" @default.
• W2775506761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29191808" @default.
• W2775506761 hasPublicationYear "2017" @default.
• W2775506761 type Work @default.
• W2775506761 sameAs 2775506761 @default.
• W2775506761 citedByCount "44" @default.
• W2775506761 countsByYear W27755067612018 @default.
• W2775506761 countsByYear W27755067612019 @default.
• W2775506761 countsByYear W27755067612020 @default.
• W2775506761 countsByYear W27755067612021 @default.
• W2775506761 countsByYear W27755067612022 @default.
• W2775506761 countsByYear W27755067612023 @default.
• W2775506761 crossrefType "journal-article" @default.
• W2775506761 hasAuthorship W2775506761A5014353069 @default.
• W2775506761 hasAuthorship W2775506761A5018814025 @default.
• W2775506761 hasAuthorship W2775506761A5019842995 @default.
• W2775506761 hasAuthorship W2775506761A5022272836 @default.
• W2775506761 hasAuthorship W2775506761A5038878574 @default.
• W2775506761 hasAuthorship W2775506761A5089382112 @default.
• W2775506761 hasAuthorship W2775506761A5091807789 @default.
• W2775506761 hasBestOaLocation W27755067611 @default.
• W2775506761 hasConcept C104317684 @default.
• W2775506761 hasConcept C134018914 @default.
• W2775506761 hasConcept C17991360 @default.
• W2775506761 hasConcept C203014093 @default.
• W2775506761 hasConcept C2776914184 @default.
• W2775506761 hasConcept C2777350992 @default.
• W2775506761 hasConcept C2779679481 @default.
• W2775506761 hasConcept C502942594 @default.
• W2775506761 hasConcept C55493867 @default.
• W2775506761 hasConcept C71924100 @default.
• W2775506761 hasConcept C86339819 @default.
• W2775506761 hasConcept C86803240 @default.
• W2775506761 hasConcept C98274493 @default.
• W2775506761 hasConceptScore W2775506761C104317684 @default.

• next